Brief: Hydration Pharmaceuticals Says Q1 Fy2022 Revenue Marks 9% Increase On Last Quarter
26/04/2022 02:35
April 26 (Reuters) - Hydration Pharmaceuticals:
* Q1 FY2022 REVENUE MARKS 9% INCREASE ON LAST QUARTER
Source text for Eikon: ID:nASX9mc3JM
Further company coverage: HPC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman